153 related articles for article (PubMed ID: 7522854)
1. Antigen-specific stimulation of histamine releasing factors in diisocyanate-induced occupational asthma.
Herd ZL; Bernstein DI
Am J Respir Crit Care Med; 1994 Oct; 150(4):988-94. PubMed ID: 7522854
[TBL] [Abstract][Full Text] [Related]
2. Characterization of histamine releasing factors in diisocyanate-induced occupational asthma.
Lummus ZL; Alam R; Bernstein JA; Bernstein DI
Toxicology; 1996 Jul; 111(1-3):191-206. PubMed ID: 8711735
[TBL] [Abstract][Full Text] [Related]
3. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma.
Lummus ZL; Alam R; Bernstein JA; Bernstein DI
J Allergy Clin Immunol; 1998 Aug; 102(2):265-74. PubMed ID: 9723671
[TBL] [Abstract][Full Text] [Related]
4. Lack of role for mononuclear cell-derived histamine releasing factors in occupational asthma due to western red cedar.
Frew AJ; Chan H; Chan-Yeung M
Clin Exp Allergy; 1993 Oct; 23(10):861-7. PubMed ID: 10780894
[TBL] [Abstract][Full Text] [Related]
5. Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma.
Bernstein DI; Cartier A; Côté J; Malo JL; Boulet LP; Wanner M; Milot J; L'Archevéque J; Trudeau C; Lummus Z
Am J Respir Crit Care Med; 2002 Aug; 166(4):445-50. PubMed ID: 12186818
[TBL] [Abstract][Full Text] [Related]
6. Diverse profiles of immunoreactivity in toluene diisocyanate (TDI) asthma.
Gallagher JS; Tse CS; Brooks SM; Bernstein IL
J Occup Med; 1981 Sep; 23(9):610-6. PubMed ID: 6268767
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor V beta gene segment expression in diisocyanate-induced occupational asthma.
Bernstein JA; Munson J; Lummus ZL; Balakrishnan K; Leikauf G
J Allergy Clin Immunol; 1997 Feb; 99(2):245-50. PubMed ID: 9042053
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of hexamethylene diisocyanate-, diphenylmethane diisocyanate-, and toluene diisocyanate-induced asthma.
Piirilä PL; Nordman H; Keskinen HM; Luukkonen R; Salo SP; Tuomi TO; Tuppurainen M
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):516-22. PubMed ID: 10934080
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in diisocyanate asthma.
Liu Q; Wisnewski AV
Ann Allergy Asthma Immunol; 2003 May; 90(5 Suppl 2):35-41. PubMed ID: 12772950
[TBL] [Abstract][Full Text] [Related]
10. Soluble human leucocyte antigen-G and interleukin-10 levels in isocyanate-induced asthma.
Mapp CE; Ferrazzoni S; Rizzo R; Miotto D; Stignani M; Boschetto P; Maestrelli P; Baricordi OR
Clin Exp Allergy; 2009 Jun; 39(6):812-9. PubMed ID: 19302248
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of basophils to histamine releasing factor(s) of various origin: dependency on allergic phenotype of the donor and surface-bound IgE.
Alam R; Forsythe PA; Rankin JA; Boyars MC; Lett-Brown MA; Grant JA
J Allergy Clin Immunol; 1990 Jul; 86(1):73-81. PubMed ID: 1695233
[TBL] [Abstract][Full Text] [Related]
12. The HLA DRB1*1501-DQB1*0602-DPB1*0501 haplotype is a risk factor for toluene diisocyanate-induced occupational asthma.
Choi JH; Lee KW; Kim CW; Park CS; Lee HY; Hur GY; Kim SH; Hong CS; Jang AS; Park HS
Int Arch Allergy Immunol; 2009; 150(2):156-63. PubMed ID: 19439981
[TBL] [Abstract][Full Text] [Related]
13. The characteristics of antigen define the cellular source and kinetics of histamine-releasing factor induced by human peripheral-blood mononuclear cells.
Turner KJ; Strickland D; Siemensma NP; Holt BJ
Int Arch Allergy Appl Immunol; 1991; 94(1-4):154-60. PubMed ID: 1718885
[TBL] [Abstract][Full Text] [Related]
14. Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes: a possible role in the mechanism of virus-induced asthma.
Chonmaitree T; Lett-Brown MA; Grant JA
J Infect Dis; 1991 Sep; 164(3):592-4. PubMed ID: 1714484
[TBL] [Abstract][Full Text] [Related]
15. Overview of diisocyanate occupational asthma.
Bernstein JA
Toxicology; 1996 Jul; 111(1-3):181-9. PubMed ID: 8711734
[TBL] [Abstract][Full Text] [Related]
16. Diisocyanate-induced asthma: diagnosis, prognosis, and effects of medical surveillance measures.
Tarlo SM; Liss GM
Appl Occup Environ Hyg; 2002 Dec; 17(12):902-8. PubMed ID: 12495601
[TBL] [Abstract][Full Text] [Related]
17. Specific IgG response to monomeric and polymeric diphenylmethane diisocyanate conjugates in subjects with respiratory reactions to isocyanates.
Aul DJ; Bhaumik A; Kennedy AL; Brown WE; Lesage J; Malo JL
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):749-55. PubMed ID: 10329805
[TBL] [Abstract][Full Text] [Related]
18. Frequency and trends of occupational asthma due to toluene diisocyanate: a critical review.
Diller WF
Appl Occup Environ Hyg; 2002 Dec; 17(12):872-7. PubMed ID: 12495598
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of IgE response to TDI-HSA conjugates by ELISA in toluene diisocyanate (TDI) -induced occupational asthma (OA) patients.
Son M; Lee M; Kim YT; Youn JK; Park H
J Korean Med Sci; 1998 Apr; 13(2):147-52. PubMed ID: 9610614
[TBL] [Abstract][Full Text] [Related]
20. A mononuclear cell derived histamine releasing factor (HRF) in asthmatic patients. Histamine release from basophils in vitro.
Alam R; Rozniecki J; Salmaj K
Ann Allergy; 1984 Jul; 53(1):66-9. PubMed ID: 6204562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
